Your browser doesn't support javascript.
loading
Robust scoring of selective drug responses for patient-tailored therapy selection.
Chen, Yingjia; He, Liye; Ianevski, Aleksandr; Ayuda-Durán, Pilar; Potdar, Swapnil; Saarela, Jani; Miettinen, Juho J; Kytölä, Sari; Miettinen, Susanna; Manninen, Mikko; Heckman, Caroline A; Enserink, Jorrit M; Wennerberg, Krister; Aittokallio, Tero.
Afiliação
  • Chen Y; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • He L; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Ianevski A; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Potdar S; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Saarela J; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Miettinen JJ; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Kytölä S; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Miettinen S; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Manninen M; Adult Stem Cell Group, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
  • Heckman CA; Research, Development and Innovation Centre, Tampere University Hospital, Tampere, Finland.
  • Enserink JM; Orton Orthopaedic Hospital, Helsinki, Finland.
  • Wennerberg K; Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
  • Aittokallio T; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Nat Protoc ; 19(1): 60-82, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37996540

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2024 Tipo de documento: Article